OneOncology launches OneR to accelerate clinical research programs

By Nikita Chaurasia  Date: 2020-10-20

OneOncology launches OneR to accelerate clinical research programs

In recent developments, Tennessee-based oncology medical service provider OneOncology Inc., has reportedly announced the establishment of a newly formed subsidiary named OneR (OneOncology Research Network).

Sources close to the matter claimed that OneR will help in accelerating research programs in community oncology practices by offering regulatory, operational and research support services for the efficient execution of multi-center clinical trials.

Moreover, the newly formed organization will apparently allow for improved patient access to healthcare professionals and will also offer clinical trial sponsors to a diverse patient population. Sources further confirmed that the subsidiary will ensure diversity during clinical trial participation with regards to socioeconomics, disease status, geography, gender, and ethnicity among other dimensions.

OneR’s emphasis towards precision oncology will aid in enhancing clinical trials across several tumor types, by utilizing innovative designs such as umbrella trials and basket trials.

For the uninitiated, basket trials show the efficacy of a new drug in patients suffering from different types of cancer, with the same mutation or biomarker. On the other hand, umbrella trials involve multiple patients with a specific type of cancer receiving treatment based on the molecular profile of their individual cancer.

Chief Medical Officer at West Cancer Center, Dr. Lee Schwartzberg, was reported stating that their primary focus of attention revolves around improving the lives of cancer patients which can be supported through scientific advancements in oncology treatments.

Axel Grothey, Medical Director at OneR, mentioned in a statement that the company’s community oncology practices with improved operational efficiencies will enable a greater number of patients to benefit from the clinical trials.

According to credible reports, the technological platform of the company will allow for seamless clinical trial management across all its research sites.

About OneOncology Inc.

OneOncology is a collaboration of independent community oncology practices that are aimed at revolutionizing cancer treatments by integrating patient-centric and technology-powered solutions in order to help improve the lives of cancer patients.

Source credits: https://www.oneoncology.com/blog/oneoncology-launches-oner-a-community-oncology-research-network

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

TCS, Infosys, Accenture workforce to receive free Covid-19 vaccination

TCS, Infosys, Accenture workforce to receive free Covid-19 vaccination

By Nikita Chaurasia

Information technology giants Infosys, Accenture India, and Tata Consultancy Services will reportedly cover Covid-19 vaccination costs for their employees and their family, who are eligible and opt to receive the jab. This news comes along the heels...

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

Motorola Solutions to offer Norwegian Health Emergency Service with CRS

By Nikita Chaurasia

Motorola Solutions has announced to have been selected by Helsetjenestens Driftsorganisasjon for Nødnett HF (HDO HF) to offer the Norwegian Health Emergency Service with a new CRS (Command Central Control Room Solution). Confirming the news,&...

Nestle India exploring options to directly sell products to consumers

Nestle India exploring options to directly sell products to consumers

By Nikita Chaurasia

Nestle India Ltd. is reportedly exploring their options of trying their hands at direct selling since consumers are largely turning towards the internet to purchase products ranging from staples to medicines amidst the COVID-19 pandemic. While the n...

Razorpay: New funding en route, meteoric rise in market value expected

Razorpay: New funding en route, meteoric rise in market value expected

By Nikita Chaurasia

Indian startup Razorpay is reportedly in discussions with Singapore-based sovereign wealth fund GIC Pvt. Ltd. and other existing investors to raise around USD 200 million in a funding round that would allow the fintech company to double its valuation...

FDA to allow pharma companies modify COVID-19 shots amid variants surge

FDA to allow pharma companies modify COVID-19 shots amid variants surge

By Nikita Chaurasia

With the rising cases of Coronavirus variants, the United States Food & Drug Administration (FDA) has reportedly introduced guidelines for pharmaceutical companies to modify their COVID-19 vaccine doses in an effort to curb the spread of the dise...